NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Stocks To Watch: AJRD, CLVS, HALO, KOPN

Published 09/19/2017, 12:41 AM
Updated 07/09/2023, 06:31 AM
NVDA
-
EXTR
-
VCEL
-
CLVSQ
-
COHU
-
HALO
-
KOPN
-
OLED
-
PGNX_old
-
LNW
-
UCTT
-
KRO
-
AJRD
-
MZOR
-
BLFS
-
RXDX_old
-
GLYC
-
SIENQ
-
BLCM
-
BZUN
-
EVBG
-
NTNX
-
VERI
-

Swing trade Aerojet Rocketdyne Holdings Inc (NYSE:AJRD) had a pop and then a breakout in Aug/Sept, it pulled back, and now it moved up 3 or 4 points. On Monday, it was up 1.91, or 6.74%, to 30.24, reaching a high of 31.39, on 2.2 million shares traded. That’s the highest this stock has been in a long time. My target is 33. If it gets through that, my next targets are upward of 38, 39, maybe even 40. Let’s get to the 33 target first. It has 4.64 days to cover .

It was a big day for Clovis Oncology Inc (NASDAQ:CLVS) on Monday, a very big day. It jumped 7.28, or 10.48%, to 76.74, on 4.5 million shares traded. The pop that it had, took out the declining topsline and is approaching lateral price resistance. The last rally attempt for this stock was at 79.10. So, that's my target for Tuesday. The moving average is at 78 1/2-79. If it gets through that, the next target will be 84-ish. It has 4.7 days to cover .

Halozyme Therapeutics Inc (NASDAQ:HALO) popped 47 cents, or 3%, to 16.72, on 5.8 million shares traded on Monday, and got all the way up to 17.55 before backing off. The target was 18.00. I think this stock may back and fill. It looks to me like it’s going to be a major short squeeze with 27 days to cover .

Kopin Corporation (NASDAQ:KOPN) had a big day on Monday. It bounced 24 cents, or 5.94%, to 4.28, on 1.4 million shares traded, which was one of the biggest volumes in the last couple months. I’m looking now for this stock to make a run at the 49-50 zone, and then blow through it. The targets are 4.75, 5.25, and eventually 6.00. There’s 10.4 days to cover .

On the long side, stocks included Applied Optoelectronics, Inc. (AAOI), Aerojet Rocketdyne Holdings, Inc. (AJRD), Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) BioLife Solutions Inc (NASDAQ:BLFS), Baozun Inc (NASDAQ:BZUN), Clovis Inc (CLVS), Cohu Inc (NASDAQ:COHU), edio, Everbridge Inc (NASDAQ:EVBG), Extreme Networks Inc (NASDAQ:EXTR), GlycoMimetics Inc (NASDAQ:GLYC), Halozyme Therapeutics, Inc. (HALO), Kopin Corporation (KOPN), Kronos Worldwide Inc (NYSE:KRO), Mazor Robotics Ltd (NASDAQ:MZOR), Nutanix Inc (NASDAQ:NTNX), NVIDIA Corporation (NASDAQ:NVDA), Universal Display (NASDAQ:OLED), Progenics Pharmaceuticals Inc (NASDAQ:PGNX), Ignyta Inc (NASDAQ:RXDX), Scientific Games Corp (NASDAQ:SGMS), Sientra Inc (NASDAQ:SIEN), Ultra Clean Holdings Inc (NASDAQ:UCTT), Vericel Corp Ord (NASDAQ:VCEL), and Veritone Inc (NASDAQ:VERI).

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.